Pretherapeutic Predictors of Tumor Absorbed Dosimetry in Radionuclide Therapy for Metastatic Neuroendocrine Tumors Abstract #2066

Introduction: Pretherapeutic 68Gallium-DOTA-(0-Tyr3)-octreotate Positron Emission Tomography (68Ga-DOTATATE PET) standardised uptake value (SUV) has shown conflicting results in the prediction of tumour lesion absorbed dosimetry (TLAD).
Aim(s): We aimed to assess the correlation of pretherapeutic SUV parameters with TLAD in patients with metastatic neuroendocrine tumours (NET).
Materials and methods: Pretherapeutic 68Ga-DOTATATE PET-CT and intra-therapeutic TLAD measured with Single Photon Emission Computer Tomography (SPECT) after cycle one were retrospectively analysed. Patients were treated with 7.45GBq Lutetium octreotate radionuclide therapy.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Nuclear Medicine - Imaging and Therapy (PRRT)
Presenting Author: Dr Rahul Ladwa

To read results and conclusion, please login ...

Further abstracts you may be interested in

No result